补阳还五汤联合川芎嗪对急性脑梗塞患者血液流变学及预后的改善分析

发布时间：2018-07-02 14:48

  本文选题：急性脑梗塞 + 补阳还五汤　； 参考：《中华中医药学刊》2017年03期

【摘要】：目的:探讨补阳还五汤联合川芎嗪对急性脑梗塞60例的血液流变学及预后的改善。方法:120例急性脑梗塞患者,通过随机数表法分为观察组和对照组,各60例。两组患者均给予常规基础治疗,对照组给予川芎嗪注射液,观察组在对照组基础上加用补阳还五汤。比较两组患者治疗效果。结果治疗后,观察组NIHSS评分低于对照组[(6.34±0.78)分vs(8.45±1.13)分](P0.05);观察组全血黏度、血浆黏度、红细胞沉降率均比对照组低[(8.74±1.14)m Pa·s vs(10.58±1.55)m Pa·s,(1.65±0.31)m Pa·s vs(2.05±0.53)m Pa·s,(19.75±2.35)mm/h vs(24.56±3.06)mm/h](P0.05);观察组治疗后总有效率高于对照组[88.33%(53/60)vs71.67%(43/60)](P0.05);两组患者治疗过程中不良反应比较无显著差异[6.67%(4/60)vs13.33%(8/60)](P0.05)。结论在急性脑梗塞患者中应用补阳还五汤联合川芎嗪效果显著,值得应用推广。
[Abstract]:Objective: to study the improvement of hemorheology and prognosis of 60 cases of acute cerebral infarction treated by Buyang Huanwu decoction and Ligustrazine. Methods 120 patients with acute cerebral infarction were randomly divided into observation group (n = 60) and control group (n = 60). Two groups of patients were given routine basic treatment, the control group was given Ligustrazine injection, and the observation group was treated with Buyang Huanwu decoction on the basis of control group. To compare the therapeutic effect between the two groups. Results after treatment, NIHSS scores in the observation group were lower than those in the control group [(6.34 卤0.78) vs (8.45 卤1.13)] (P0.05); 绾㈢粏鑳炴矇闄嶇巼鍧囨瘮瀵圭収缁勪綆[(8.74卤1.14)m Pa路s vs(10.58卤1.55)m Pa路s,(1.65卤0.31)m Pa路s vs(2.05卤0.53)m Pa路s,(19.75卤2.35)mm/h vs(24.56卤3.06)mm/h](P0.05);瑙傚療缁勬不鐤楀悗鎬绘湁鏁堢巼楂樹簬瀵圭収缁刐88.33%(53/60)vs71.67%(43/60)](P0.05);涓ょ粍鎮ｈ，

本文编号：2090466